PAUL A FRIEDMAN Insider Trading $VSTM Verastem, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL A FRIEDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).

PAUL A FRIEDMAN in Verastem, Inc.

Trading Symbol: VSTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2016
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL A FRIEDMAN in Verastem, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 16 2016VSTMVerastem, Inc.FRIEDMAN PAUL ADirectorOption ExerciseA1.3725,00034,25025,000
Jun 16 2015VSTMVerastem, Inc.FRIEDMAN PAUL ADirectorOption ExerciseA7.9919,495155,76519,495

Page:   1